1 ed by nail psoriasis and current or previous dactylitis.

2 d clinical signs of psoriatic enthesitis and dactylitis.

3 h groups, however, share a high frequency of dactylitis.

4 rs of life for (1) painful events other than dactylitis, (2) dactylitis, and (3) acute chest syndrome

5  patients in the placebo group, p=0.002) and dactylitis (24 events in 14 patients vs 123 events in 42

6 s of initial and recurrent episodes of pain, dactylitis, acute chest syndrome, and hospitalization; e

7 ical outcome (vaso-occlusive painful crisis, dactylitis, acute chest syndrome, splenic sequestration,

8 tients are more likely to be female, exhibit dactylitis and small joint involvement, and express anti

9 ation (including joint count, evaluation for dactylitis and/or enthesitis, and skin examination) and

10 1) painful events other than dactylitis, (2) dactylitis, and (3) acute chest syndrome (ACS).

11 who were asymptomatic at enrollment had less dactylitis as well as fewer hospitalizations and transfu

12 dictors of an adverse outcome: an episode of dactylitis before the age of one year (relative risk of

13                                              Dactylitis had limited utility as a predictor.

14                           The combination of dactylitis of a toe, heel pain, and oligoarthritis appea

15 subgroups but suggested that the presence of dactylitis, rather than age, has the greatest capacity t

16 e Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very youn

17 t may appear in the first two years of life (dactylitis, severe anemia, and leukocytosis) can help to

18  of key clinical domains (joints, enthesium, dactylitis, spine, and skin and nails), and coming to co